Double autophagy modulators reduce 2-deoxyglucose uptake in sarcoma patients
Authors:
Open Access
- 7 September 2015
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (30) , 29808-29817
Abstract
Double autophagy modulators reduce 2-deoxyglucose uptake in sarcoma patientsKeywords
This publication has 29 references indexed in Scilit:
- The Synergistic Effect of Everolimus and Chloroquine on Endothelial Cell Number Reduction Is Paralleled by Increased Apoptosis and Reduced Autophagy OccurrencePLOS ONE, 2013
- Stromal–epithelial metabolic coupling in cancer: Integrating autophagy and metabolism in the tumor microenvironmentThe International Journal of Biochemistry & Cell Biology, 2011
- The autophagic tumor stroma model of cancer or “battery-operated tumor growth”Cell Cycle, 2010
- Autophagy in cancer associated fibroblasts promotes tumor cell survivalCell Cycle, 2010
- Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolutionCell Cycle, 2010
- Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: Implications for breast cancer and DCIS therapy with autophagy inhibitorsCell Cycle, 2010
- Efficacy of RAD001 (Everolimus) and Octreotide LAR in Advanced Low- to Intermediate-Grade Neuroendocrine Tumors: Results of a Phase II StudyJournal of Clinical Oncology, 2008
- Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trialThe Lancet, 2008
- The impact of hypoxia on the activity of lactate dehydrogenase in two different pre-clinical tumour modelsActa Oncologica, 2008
- Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendationsEuropean Journal of Cancer, 1999